Back to search

Article

Safety and Efficacy of Rituximab in Systemic Sclerosis: A Systematic Review and Meta-analysis

2019-12-16

Abstract excerpt

<title>Abstract</title> <p>Background: Rituximab has been widely proposed to treat systemic sclerosis (SSc) by depletion of pathogenic B cells. Nonetheless, the clinical benefit of Rituximab in SSc remains contentious. <h4>Objective:</h4> This meta-analysis was conducted to systematically evaluate the safety and efficacy profile of Rituximab in SSc patients. <h4>Methods:</h4> We performed a systematic online quer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
981ccf57-d3e0-53da-9004-7d51079267bf
DOI
10.21203/rs.2.18603/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety and Efficacy of Rituximab in Systemic Sclerosis: A Systematic Review and Meta-analysisDOI 10.21203/rs.2.18603/v1
Select a neighboring publication to make it the new centre.